What will the IVF lab look like in five years?Trying to predict and shape that response is Dr. Denny Sakkas, Chief Scientific Officer at Boston IVF and head of the scientific advisory board for AutoIVF.In this episode of Inside Reproductive Health, Dr. Sakkas about what automation really means for embryologists, and how new technologies could transform lab operations, chain of custody, and patient safety.Dr. Sakkas shares:– The potential downsides to automation and where caution is needed– How AutoIVF differs from AURA by Conceivable Life Sciences– His prediction about time-lapse imaging within five years– The areas where embryologists must hold firm on lab standards– The next big innovations he’s watching (and what Boston IVF plans to purchase next year)
--------
45:24
--------
45:24
267 What IVY Fertility is Using And Why. Amy Jones
Lab directors, how do you make sure your concerns actually reach ownership?Vendors, how are you being vetted by the groups you serve?This week on Inside Reproductive Health, Amy Jones, Chief Quality Officer of Ivy Fertility, talks about how one of the country’s leading networks evaluates quality, chooses partners, and plans for growth.Amy shares:– The specific criteria Ivy uses to vet vendors for cryostorage and digital witnessing– How they’re implementing an AI solution to compare data across EMRs– The patient concierge platform guiding patients through the IVF journey– Where current patient education tools fall short– The tradeoffs of proactive expansion– And why fertility professionals get into trouble when they stay “too stuck in their own lane”
--------
37:09
--------
37:09
266 Break the IVF Cartel. Dr. Francisco Arredondo, Dr. Robert Kiltz
What’s the definition of a cartel, and has the way we pay for care created one in fertility?This week on Inside Reproductive Health, two practice-owning REIs with very different models join Griffin to push that question hard. Dr. Robert Kiltz (CNY Fertility) and Dr. Francisco Arredondo (Pozitvf IVF & The IVF Academy) dig into the economics, the ethics, and the possible alternatives to the status quo.They discuss:Dr. Arredondo’s argument that today’s IVF system resembles a cartel (and what can be done about it)The right question to ask about access and cost in IVFHow insurance helped create today’s medical-industrial complexDr. Kiltz’s meeting with HHS leadership and what it revealedLessons from Aravind Eye Care in India (Could that model work for IVF?)What the IVF Academy is teaching clinicians about entrepreneurship and sustainable practiceThis episode doesn’t offer easy answers. It’s a clear-eyed conversation about structural incentives, mission, and what it will take to make IVF more affordable and accessible.
--------
58:09
--------
58:09
265 The Leadership Lesson. Dr. Alison Bartolucci. Cara Reymann.
If you’ve ever tried to get doctors, embryologists, and executives on the same page…you’ll want to hear this one.In this episode of Inside Reproductive Health, Dr. Alison Bartolucci (CSO) and Cara Reymann (CEO) of First Fertility talk candidly about leadership, lab management, and network-wide decision-making.They discuss:– The emotional cost of leading a fertility network– When to build consensus (and when to just drive the bus)– The decision to implement digital witnessing across all nine IVF labs– The “magic question” Cara uses to align stakeholders– Why First Fertility abandoned plans for a single EMR– Why Alison swears by using a lab monitoring service (and the business benefits beyond happy embryologists)
--------
56:46
--------
56:46
264 Overwhelmed on a Daily Basis. Fertility Doctors Respond to Genetic Risk.
Overwhelm. Anxiety. Cases that stay with you.That’s how some of the field’s most experienced professionals describe genetics in reproductive medicine today.In this episode of Inside Reproductive Health, we brought together leaders from RMA, CCRM, Shady Grove, and GeneScreen to talk about the genetics overload in modern ART.They talk with Griffin about:The liability landmine that genetics has becomeWhy one lab’s “positive” is another lab’s “negative” (The Panel Paradox)Real cases where rare findings blindsided experienced REIsSmart strategies to stratify counseling (Without missing critical risks)The growing complexity of third-party reproductionThe coming wave of whole genome sequencing and polygenic risk scoresThis isn’t a high-level overview. It’s a blunt conversation about the real risks, broken workflows, and what’s coming next for your lab and patients.
Inside Reproductive Health is your source for information about the growing field of fertility. Inside Reproductive Health features an active blog and weekly interviews with leaders from the clinical, investment, patient relations, and pharmaceutical corners of reproductive medicine. Be sure to subscribe to our podcast and check back frequently for new content!
Ouça Inside Reproductive Health Podcast, Isso não é uma sessão de análise, com Vera Iaconelli e muitos outros podcasts de todo o mundo com o aplicativo o radio.net
Brasil